LEP and obesity due to melanocortin 4 receptor deficiency: Based on these observations, it is reasonable to suggest that pharmacological approaches targeting leptin's effects could represent a potentially useful therapeutic strategy for the treatment of obesity-associated hypertension among other cardiovascular disease.